National Health (Weighted average disclosed price – October 2016 reduction day) Amendment Determination 2016 (No. 1) (PB 80 of 2016) (Cth)

Case

PB 80 of 2016

National Health (Weighted average disclosed price – October 2016 reduction day) Amendment Determination 2016 (No.1)

National Health Act 1953

I, PENNY SHAKESPEARE, First Assistant Secretary, Pharmaceutical Benefits Division, Department of Health, delegate of the Minister for Health, make this determination under subsection 99ADB(4) of the National Health Act 1953.

Dated:        31 August 2016

PENNY SHAKESPEARE

First Assistant Secretary
Pharmaceutical Benefits Division
Department of Health

  1. Name of Determination

(1)     This Determination is the National Health (Weighted average disclosed price – October 2016 reduction day) Amendment Determination 2016 (No.1).

(2)     This Determination may also be cited as PB 80 of 2016.

  1. Commencement

    This Determination commences on the day after it is registered.

  1. Amendments to PB 39 of 2016

    Schedule 1 amends the National Health (Weighted average disclosed price – October 2016 reduction day) Determination 2016 (PB 39 of 2016).

Schedule 1       Amendments

[1]     Schedule 1

after:

327 Celecoxib Capsule 200 mg Oral Terry White Chemists Celecoxib 9.42

insert:

327A Citalopram Tablet 10 mg (as hydrobromide) Oral Celapram 0.90
327B Citalopram Tablet 10 mg (as hydrobromide) Oral Citalopram Actavis 0.90
327C Citalopram Tablet 10 mg (as hydrobromide) Oral Citalopram-GA 0.90
327D Citalopram Tablet 10 mg (as hydrobromide) Oral Talam 0.90

[2]     Schedule 1

omit:

328 Cisplatin I.V. injection 100 mg in 100 mL Injection Cisplatin Ebewe 13.45
329 Cisplatin I.V. injection 100 mg in 100 mL Injection Hospira Pty Limited 13.45
330 Cisplatin I.V. injection 50 mg in 50 mL Injection Hospira Pty Limited 7.26

[3]     Schedule 1

omit:

442 Dorzolamide Eye drops 20 mg (as hydrochloride) per mL, 5 mL Application to the eye Trusamide 4.15
443 Dorzolamide Eye drops 20 mg (as hydrochloride) per mL, 5 mL Application to the eye Trusopt 4.15

[4]     Schedule 1

omit:

444 Dorzolamide with timolol Eye drops containing dorzolamide 20 mg (as hydrochloride) with timolol 5 mg (as maleate) per mL, 5 mL Application to the eye Cosdor 11.10
445 Dorzolamide with timolol Eye drops containing dorzolamide 20 mg (as hydrochloride) with timolol 5 mg (as maleate) per mL, 5 mL Application to the eye Cosopt 11.10
446 Dorzolamide with timolol Eye drops containing dorzolamide 20 mg (as hydrochloride) with timolol 5 mg (as maleate) per mL, 5 mL Application to the eye Dorzolamide/Timolol Sandoz 20/5 11.10

substitute:

444 Dorzolamide with timolol Eye drops containing dorzolamide 20 mg (as hydrochloride) with timolol 5 mg (as maleate) per mL, 5 mL Application to the eye Cosdor 12.08
445 Dorzolamide with timolol Eye drops containing dorzolamide 20 mg (as hydrochloride) with timolol 5 mg (as maleate) per mL, 5 mL Application to the eye Cosopt 12.08
446 Dorzolamide with timolol Eye drops containing dorzolamide 20 mg (as hydrochloride) with timolol 5 mg (as maleate) per mL, 5 mL Application to the eye Dorzolamide/Timolol Sandoz 20/5 12.08

[5]     Schedule 1

omit:

504 Epirubicin Solution for injection containing epirubicin hydrochloride 100 mg in 50 mL Injection/intravesical Epirubicin ACT 23.36
505 Epirubicin Solution for injection containing epirubicin hydrochloride 100 mg in 50 mL Injection/intravesical Hospira Pty Limited 23.36
506 Epirubicin Solution for injection containing epirubicin hydrochloride 200 mg in 100 mL Injection/intravesical DBL Epirubicin Hydrochloride Injection 46.67
507 Epirubicin Solution for injection containing epirubicin hydrochloride 200 mg in 100 mL Injection/intravesical Epirubicin ACT 46.67
508 Epirubicin Solution for injection containing epirubicin hydrochloride 200 mg in 100 mL Injection/intravesical Epirubicin Kabi 46.67
509 Epirubicin Solution for injection containing epirubicin hydrochloride 50 mg in 25 mL Injection/intravesical Epirubicin ACT 11.70
510 Epirubicin Solution for injection containing epirubicin hydrochloride 50 mg in 25 mL Injection/intravesical Epirubicin SZ 11.70
511 Epirubicin Solution for injection containing epirubicin hydrochloride 50 mg in 25 mL Injection/intravesical Hospira Pty Limited 11.70

[6]     Schedule 1

after:

617 Flucloxacillin Powder for injection 1 g (as sodium) Injection Hospira Pty Limited 4.95

insert:

617A Flucloxacillin Powder for injection 500 mg (as sodium) Injection Flubiclox 1.49

[7]     Schedule 1

after:

636 Fluorouracil Injection 500 mg in 10 mL Injection Hospira Pty Limited 16.09

insert:

636A Fluorouracil Injection 5000 mg in 100 mL Injection Fluorouracil Ebewe 32.18

[8]     Schedule 1

omit:

826 Irinotecan I.V. injection containing irinotecan hydrochloride trihydrate 100 mg in 5 mL Injection Hospira Pty Limited 13.62
827 Irinotecan I.V. injection containing irinotecan hydrochloride trihydrate 100 mg in 5 mL Injection Irinoccord 13.62
828 Irinotecan I.V. injection containing irinotecan hydrochloride trihydrate 100 mg in 5 mL Injection Irinotecan Alphapharm 13.62
829 Irinotecan I.V. injection containing irinotecan hydrochloride trihydrate 100 mg in 5 mL Injection Irinotecan Ebewe 13.62
830 Irinotecan I.V. injection containing irinotecan hydrochloride trihydrate 100 mg in 5 mL Injection Irinotecan Kabi 13.62
831 Irinotecan I.V. injection containing irinotecan hydrochloride trihydrate 100 mg in 5 mL Injection Irinotecan MYX 13.62
832 Irinotecan I.V. injection containing irinotecan hydrochloride trihydrate 100 mg in 5 mL Injection Omegapharm Irinotecan 13.62
833 Irinotecan I.V. injection containing irinotecan hydrochloride trihydrate 300 mg in 15 mL Injection Irinotecan Ebewe 40.85
834 Irinotecan I.V. injection containing irinotecan hydrochloride trihydrate 40 mg in 2 mL Injection Irinoccord 5.45
835 Irinotecan I.V. injection containing irinotecan hydrochloride trihydrate 40 mg in 2 mL Injection Irinotecan Alphapharm 5.45
836 Irinotecan I.V. injection containing irinotecan hydrochloride trihydrate 40 mg in 2 mL Injection Irinotecan Ebewe 5.45
837 Irinotecan I.V. injection containing irinotecan hydrochloride trihydrate 40 mg in 2 mL Injection Omegapharm Irinotecan 5.45
838 Irinotecan I.V. injection containing irinotecan hydrochloride trihydrate 500 mg in 25 mL Injection Hospira Pty Limited 68.09
839 Irinotecan I.V. injection containing irinotecan hydrochloride trihydrate 500 mg in 25 mL Injection Irinotecan Actavis 500 68.09
840 Irinotecan I.V. injection containing irinotecan hydrochloride trihydrate 500 mg in 25 mL Injection Irinotecan Alphapharm 68.09
841 Irinotecan I.V. injection containing irinotecan hydrochloride trihydrate 500 mg in 25 mL Injection Irinotecan Ebewe 68.09

[9]    Schedule 1

after:

1783 Sumatriptan Tablet 50 mg (as succinate) Oral Terry White Chemists Sumatriptan 2.69

insert:

1783A Tamoxifen Tablet 10 mg (as citrate) Oral Genox 10 10.21

[10]   Schedule 2

omit:

295 Ceftriaxone Powder for injection 500 mg (as sodium) Injection Ceftriaxone-AFT 0.99

[11]   Schedule 2

omit:

371 Citalopram Tablet 10 mg (as hydrobromide) Oral Celapram 1.06
372 Citalopram Tablet 10 mg (as hydrobromide) Oral Citalopram Actavis 1.06
373 Citalopram Tablet 10 mg (as hydrobromide) Oral Citalopram-GA 1.06
374 Citalopram Tablet 10 mg (as hydrobromide) Oral Talam 1.06

[12]   Schedule 2

after:

489 Docetaxel Solution concentrate for I.V. infusion 80 mg in 8 mL Injection Docetaxel Sandoz 14.81

insert:

489A Dorzolamide Eye drops 20 mg (as hydrochloride) per mL, 5 mL Application to the eye Trusamide 9.22
489B Dorzolamide Eye drops 20 mg (as hydrochloride) per mL, 5 mL Application to the eye Trusopt 9.22

[13]   Schedule 2

omit:

499 Doxycycline Capsule 50 mg (as hydrochloride) (containing enteric coated pellets) Oral Doryx 1.57
500 Doxycycline Capsule 50 mg (as hydrochloride) (containing enteric coated pellets) Oral Mayne Pharma Doxycycline 1.57

[14]   Schedule 2

omit:

584 Flucloxacillin Powder for injection 500 mg (as sodium) Injection Flubiclox 2.66

[15]   Schedule 2

omit:

592 Fluorouracil Injection 5000 mg in 100 mL Injection Fluorouracil Ebewe 46.16

[16]   Schedule 2

after:

1055 Morphine Capsule containing morphine sulfate 90 mg (controlled release) Oral MS Mono 26.12

insert:

1055A Morphine Injection containing morphine hydrochloride 10 mg in 1 mL Injection Morphine Juno 6.34
1055B Morphine Injection containing morphine hydrochloride 100 mg in 5 mL Injection Morphine Juno 26.97
1055C Morphine Injection containing morphine hydrochloride 20 mg in 1 mL Injection Morphine Juno 9.71
1055D Morphine Injection containing morphine hydrochloride 50 mg in 5 mL Injection Morphine Juno 16.19

[17] Schedule 2

after:

1535 Tacrolimus Capsule 0.5 mg (once daily prolonged release) Oral Prograf XL 37.52

insert:

1535A Tacrolimus Capsule 0.75 mg Oral Tacrolimus Sandoz 170.29

[18] Schedule 2

after:

1540 Tacrolimus Capsule 1 mg (once daily prolonged release) Oral Prograf XL 136.30

insert:

1540A Tacrolimus Capsule 2 mg Oral Tacrolimus Sandoz 454.10

[19] Schedule 2

omit:

1546 Tamoxifen Tablet 10 mg (as citrate) Oral Genox 10 12.15
Actions
Download as PDF Download as Word Document


Cases Citing This Decision

0

Cases Cited

0

Statutory Material Cited

0